Best neocloud stocks: CRWV, NBIS, and IREN compared
Best neocloud stocks: CRWV, NBIS, and IREN compared
The neocloud race is a study in three very different risk profiles: CRWV is the proven revenue engine, NBIS is the hypergrowth rocket already up +211% in a year, and IREN is the scrappy Bitcoin-miner-turned-AI-cloud-builder with a blockbuster Microsoft contract. On valuation, CRWV wins — 26.7% Fair Value upside and the cheapest EV/EBITDA of the three at 23.9x — while NBIS looks priced for perfection and IREN is burning cash at a historic pace to fund a massive strategic pivot.
The Scoreboard
All prices as of Sep 2, 2026 close; pre-market data as of Sep 3, 9:09 AM EDT. Screener-derived metrics are snapshots and may lag live prices.
| Metric | CRWV | NBIS | IREN |
|---|---|---|---|
| Price | $80.93 | $204.09 | $39.60 |
| Market Cap | $44.64B | $55.94B | $15.60B |
| LTM Revenue | $5.13B | $529.8M | $707.0M |
| Revenue Growth | +115.3% | +506.9% | +41.1% |
| EV/EBITDA | 23.9x | 218.9x | 457.6x |
| P/S | 5.9x | 41.3x | 22.1x |
| Fair Value Upside | +26.7% | -9.3% | +0.9% |
| Analyst Upside | +85.3% | +40.9% | +102.0% |
| D/E Ratio | 1,027% | 98.6% | 187.3% |
| FCF (latest FY) | -$7.25B | -$3.68B | -$2.23B |
| 1-Year Return | -10.0% | +210.9% | +40.4% |
CRWV: Scale wins the first round
CRWV is the only true scaled neocloud of the three — $5.13B in FY2025 revenue after growing from just $229M two years prior. That’s a trajectory few cloud businesses in history have matched. The forward EBITDA ramp is real: analysts model $2.92B by end of FY2026, making the 23.9x EV/EBITDA look almost reasonable for a business this early in its arc. Truist’s recent price target hike (citing a 25% pricing increase in July adding ~9 points of margin) signals that pricing power is emerging. The 85.3% analyst consensus upside is the widest of the three, and a $102.52 Fair Value implies 26.7% upside from current levels.
The bear case is the balance sheet: D/E at 1,027% and -$7.25B FCF are not typos. CRWV is essentially a levered bet on sustained AI GPU demand — if hyperscaler capex cycles turn, this becomes the riskiest name fast.
NBIS: The fastest engine, the richest price tag
NBIS is posting +506.9% revenue growth LTM — and the EBITDA inflection is arriving fast, with analysts projecting $666.4M EBITDA in Q4 2026 after two years of losses. Being first to deploy Nvidia’s Groq 3 LPX accelerator is a genuine moat signal — that’s a preferential relationship that moves GPUs before competitors. Goldman Sachs has a Street-high $328 price target (Buy), and the $5.75B convertible notes offering closed above target, confirming institutional appetite.
The problem: at P/S of 41.3x and with Fair Value models suggesting -9.3% downside at the current price, NBIS is the most richly priced of the three. After a +211% one-year run, a significant portion of the growth story appears already in the stock. The $20-25B capex guide is enormous relative to current revenue.
IREN: The wild card with a $9.7B catalyst
IREN is the most complex story. The Bitcoin-miner-to-AI-cloud pivot is now complete — AI Cloud became 51% of Q4 FY2026 revenue ($70.5M), and management targets >$4B ARR by December 2026 after Microsoft accepted Horizon 1 of a $9.7B contract. Blue Owl just led a $2.4B financing for Blackwell Ultra GPU procurement. The optionality on the 1.4 GW West Texas site alone could be worth billions.
But Q4 revenue missed by 12.7%, EBITDA compressed to just $38.35M in FY2026 (from $201.7M a year prior due to mining write-offs), and with a -$2.23B FCF and a $25-30B FY2027 capex plan, execution risk is high. Fair Value implies only +0.9% upside — the market is already pricing considerable ARR ramp-up.
The Verdict
| Profile | Best Pick |
|---|---|
| Best valuation | CRWV — cheapest EV/EBITDA, widest FV upside |
| Best growth | NBIS — 506% revenue growth, EBITDA turning positive |
| Highest upside optionality | IREN — Microsoft contract + 5GW pipeline |
| Best risk-adjusted | CRWV — proven at scale, analyst consensus 85% upside |
CRWV edges out as the most compelling risk-adjusted opportunity: it has the revenue proof, the improving margin story (pricing power confirmed), the largest analyst upside, and a clear Fair Value gap — all while trading -10% from a year ago. NBIS is the momentum pick for those who believe the valuation will catch up to growth (Goldman clearly does). IREN’s Microsoft ARR ramp is a high-conviction story if you trust management execution — but it’s a binary bet on a company still mid-pivot with compressed near-term EBITDA.